Abstract
Natural products are essential to human life, and about half of the medications used in clinical practice today are of natural origin. The present work investigated to isolate and identify active compounds with anti-diabetic activity from Scindapsus officinalis fruits and confirm the isolated compounds' mode of action, affinity, and domain specificity relationships. Some fractions of S. officinalis ethanolic extracts were subjected to column chromatography and preparative TLC and two compounds namely 2E,4E,6E)-5-methyl-7-(2,6,6-trimethylcyclohexa-2,4-dien-1-yl)hepta-2,4,6-trien-1-ol (CN-501A) and 9-(furan-3-yl)-4-hydroxy-1,5,6,6a,9,10,10a,10b-octahydro-3H,7H-pyrano[3,4-f]isochromene-3,7-dione (CN-501B) were isolated in pure form. The structures of the isolated compounds were confirmed by UV, IR, 1H NMR and mass spectral data. The anti diabetic activity was measured using a molecular docking study and the three-dimensional structure of the target protein was downloaded from PDB. The Docking study recommended that CN – 501A and CN – 501B are existing photochemical from the plant of S. officinalis had the highest fitness docking score and hence could be a possible antidiabetic drug.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
